This outcomes research guide explores how integrating eCOA and connected medical devices can modernize obesity clinical trials by capturing richer patient-centered data, improving engagement, and strengthening regulatory evidence. Designed for pharma sponsors, it outlines best practices to drive higher-quality endpoints and more meaningful trial outcomes in an increasingly competitive obesity landscape.
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
.svg){kind=icon}
